Wyeth PhRMA Honors Wyeth Oncology Researchers with
2003 DISCOVERERS
AWARD
Three Wyeth Discovery Research scientists who worked for nearly 19 years to contribute to the development of an antibody-targeted chemotherapy have been honored with the prestigious 2003 Discoverers Award from the Pharmaceutical Research and Manufacturers of America (PhRMA). The research contributions of Drs. George Ellestad, Philip Hamann, and Janis Upeslacis led to the development of this breakthrough medicine.
PhRMA presents the Discoverers Award each year to scientists whose research and development of pharmaceuticals have greatly benefited humankind and whose dedication and interest in improving the quality of life of patients exemplify the best in the research-based pharmaceutical industry today.
Winning this award reaffirms Wyeth's commitment to innovation as one of the leading research and development organizations in the pharmaceutical industry.
We have excellent career opportunities. For more information visit us at:
www.wyethjobs.com An Equal Opportunity Employer M/F/D/V
